Share Email Print

Proceedings Paper

Monitoring photodynamic therapy of intracranial neoplasms using functional CT imaging technique
Author(s): J. Darko
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Photodynamic therapy (PDT) is an innovative and attractive modality, which is potentially beneficial for the treatment of a number of cancers either as stand-alone or as adjuvant treatment. Currently PDT is in a Phase III clinical trial for the treatment of intracanial neoplasms using Photofrin as the Photosensitizer (Muller et al). Selectivity of PDT treatment is based on the inherent selectivity of the photosensitizer towards malignant cells and light fluence distribution within the tissue of a monochromatic source that matches the absorption spectrum of the sensitizer. However, there is currently, no individualized dosimetry or monitoring system for treatment progress using either a direct or indirect biological responses, available, which would enable the physician to modify the treatment or repeat it while photosensitizer in under treated tissue is still available.

Paper Details

Date Published: 29 August 2017
PDF: 3 pages
Proc. SPIE 10313, Opto-Canada: SPIE Regional Meeting on Optoelectronics, Photonics, and Imaging, 1031335 (29 August 2017); doi: 10.1117/12.2283909
Show Author Affiliations
J. Darko, Princess Margaret Hospital (Canada)

Published in SPIE Proceedings Vol. 10313:
Opto-Canada: SPIE Regional Meeting on Optoelectronics, Photonics, and Imaging
John C. Armitage, Editor(s)

© SPIE. Terms of Use
Back to Top